AU2001243617A1 - Use of a combination of agents that modulate b7 activity in inhibiting intestinal allograft rejection - Google Patents

Use of a combination of agents that modulate b7 activity in inhibiting intestinal allograft rejection

Info

Publication number
AU2001243617A1
AU2001243617A1 AU2001243617A AU4361701A AU2001243617A1 AU 2001243617 A1 AU2001243617 A1 AU 2001243617A1 AU 2001243617 A AU2001243617 A AU 2001243617A AU 4361701 A AU4361701 A AU 4361701A AU 2001243617 A1 AU2001243617 A1 AU 2001243617A1
Authority
AU
Australia
Prior art keywords
modulate
agents
activity
combination
allograft rejection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001243617A
Inventor
Mary Collins
Kenneth Newell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Arch Development Corp
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Publication of AU2001243617A1 publication Critical patent/AU2001243617A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2827—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against B7 molecules, e.g. CD80, CD86
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001243617A 2000-03-14 2001-03-13 Use of a combination of agents that modulate b7 activity in inhibiting intestinal allograft rejection Abandoned AU2001243617A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18916500P 2000-03-14 2000-03-14
US60189165 2000-03-14
PCT/US2001/008015 WO2001068132A1 (en) 2000-03-14 2001-03-13 Use of a combination of agents that modulate b7 activity in inhibiting intestinal allograft rejection

Publications (1)

Publication Number Publication Date
AU2001243617A1 true AU2001243617A1 (en) 2001-09-24

Family

ID=22696204

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001243617A Abandoned AU2001243617A1 (en) 2000-03-14 2001-03-13 Use of a combination of agents that modulate b7 activity in inhibiting intestinal allograft rejection

Country Status (3)

Country Link
US (1) US20020071839A1 (en)
AU (1) AU2001243617A1 (en)
WO (1) WO2001068132A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7304149B2 (en) * 2002-06-20 2007-12-04 Washington University In St. Louis BTLA nucleic acids
PL2344540T3 (en) 2008-10-02 2018-05-30 Aptevo Research And Development Llc Cd86 antagonist multi-target binding proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2292415A1 (en) * 1997-06-20 1998-12-30 Innogenetics N.V. B7-binding molecules for treating immune diseases
PL350909A1 (en) * 1999-02-12 2003-02-10 Genetics Inst Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith

Also Published As

Publication number Publication date
WO2001068132A1 (en) 2001-09-20
US20020071839A1 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
TWI318207B (en) Carbamate caspase inhibitors and uses thereof
AU1897700A (en) Removable stent
AU3620600A (en) Skin-marking devices and their use
SG86414A1 (en) Sanitary tampon
AU2820000A (en) Assembly of a cleansing device and one or more cleansing elements
MXPA03004714A (en) Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents.
AU2001268197A1 (en) Human pancreatic islet glucose-6-phosphatase
AU1752901A (en) Articulating earplug
AU2460100A (en) Masking agent
AU5493400A (en) Absorbent airlaid structure
ZA200102956B (en) Use of ophthalmic composition comprising vitamin A and Vitamin E.
AU2001276149A1 (en) Cleaning and disinfecting agent
IL151589A0 (en) New combination of a betablocker and a cholestrol-lowering agent
AU2001270129A1 (en) Human phosphodiesterases
AU3328600A (en) Ocular tension-lowering agents
AU140179S (en) Earplug dispenser
AU2501200A (en) Human peptidases
AU2001243617A1 (en) Use of a combination of agents that modulate b7 activity in inhibiting intestinal allograft rejection
AU1056399A (en) Sanitary devices and a toilet
AU4432001A (en) Trityl-type compounds and their use
AU2001241875A1 (en) Human dynamin 40322
GB0021497D0 (en) Compounds and their use
AU2001249182A1 (en) Use of rapamycin and agents that inhibit b7 activity in immunomodulation
AU2529501A (en) Macrocyclic compounds and their use
AU2001218611A1 (en) Stent